Girl Planting seeds

Blood pressure medication recall continues to expand

A recall on blood pressure medication first announced in April has been expanded. Teva Pharmaceuticals USA Inc. issued a voluntary recall for losartan potassium tablets that may contain N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) at levels higher than the FDA's acceptable exposure limit. NMBA, which has been shown to cause cancer in rats, qualifies as a known animal carcinogen and a potential human carcinogen. The expanded recall involves six lots of bulk losartan potassium USP tablets — two are 50 mg strength tablets, while the other four are 100 mg strength tablets.  Read more....
 

 

Back

 
 
close (X)